Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
von Lewinski, D; Bisping, E; Elgner, A; Kockskämper, J; Pieske, B.
Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium.
Eur J Heart Fail. 2007; 9(11):1086-1094
Doi: 10.1016/j.ejheart.2007.08.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Pieske Burkert Mathias
-
von Lewinski Dirk
- Co-Autor*innen der Med Uni Graz
-
Bisping Egbert Hubertus
-
Kockskämper Jens
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background: Cardiac glycosides are characterized by a narrow therapeutic range with Ca2+ -overload and arrhythmias occurring at higher concentrations. Data on cardiac glycosides in isolated failing human myocardium are scarce and the frequency-dependent actions and toxicity of Strophanthidin have not yet been characterized. Aims: To determine inotropic responses and toxicity of Strophanthidin in failing human myocardium. Methods and results: Experiments were performed in trabeculae from 64 end-stage failing hearts. Developed force, and intracellular [Ca2+] and [Na+](i) were recorded with Strophanthidin (0.01 to 1 mu mol/L; 37 degrees C, 1 Hz) and compared to interventions with distinct mechanisms of action (elevated [Ca2+](o), Isoproterenol, and EMD57033). The effects of Strophanthidin on force-frequency behaviour were also assessed. Strophanthidin exerted concentration-dependent positive inotropic effects. These were paralleled by increases in intracellular [Na+] as well as increasing [Ca2+](i)-transients and SR-Ca2+-load. At high concentrations (>0.5 mu mol/L), Strophanthidin caused afterglimmers and aftercontractions, with declining developed force despite further increasing [Ca2+](i)-transients. The force-frequency-relationship and diastolic function at higher pacing rates was worsened by Strophanthidin in a concentration-dependent manner. Conclusions: Strophanthidin toxicity was dependent on concentration, calcium load, beating rate and beta-adrenergic receptor activation. Our data support the view that low doses, heart rate control and additional P-adrenergic receptor blockade are essential in the use of cardiac glycosides in heart failure. (c) 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
-
Cardiotonic Agents - pharmacology Cardiotonic Agents - toxicity
-
Diastole - drug effects
-
Female -
-
Heart Failure - metabolism Heart Failure - physiopathology
-
Humans -
-
Isoproterenol - pharmacology Isoproterenol - toxicity
-
Male -
-
Middle Aged -
-
Myocardial Contraction - drug effects
-
Sodium-Calcium Exchanger - drug effects
-
Strophanthidin - pharmacology Strophanthidin - toxicity
-
Systole - drug effects
- Find related publications in this database (Keywords)
-
cardiac glycosides
-
human myocardium
-
calcium
-
contractile function
-
arrhythmias